Indivior PLC (LON:INDV – Get Rating) shares crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 305.90 ($3.66) and traded as high as GBX 309.20 ($3.70). Indivior shares last traded at GBX 299 ($3.57), with a volume of 1,129,974 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Morgan Stanley started coverage on Indivior in a research report on Friday, March 25th. They set an “equal weight” rating and a GBX 330 ($3.95) price target for the company.
Indivior Stock Down 0.5 %
The company has a quick ratio of 1.58, a current ratio of 1.74 and a debt-to-equity ratio of 121.55. The stock has a 50-day simple moving average of GBX 305.90 and a 200-day simple moving average of GBX 282.62. The firm has a market capitalization of £2.08 billion and a PE ratio of 1,495.88.
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia.
Featured Articles
- Exxon Mobil Leads The Oil Sector: Have Both Peaked?
- Get These 3 Juicy Dividend Yields While They Last
- These 3 Mega Caps are Bear Market Buys
- How Low Can DocuSign Stock Go?
- The Top-Rated Consumer Defensive Stocks With Yield Above 3.5%
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
